Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy
Genetic polymorphisms in the genes that encode drug-metabolizing enzymes are implicated in the inter-individual variability in the pharmacokinetics and pharmaco-dynamics of antiepileptic drugs (AEDs). However, the clinical impact of these polymorphisms on AED therapy still remains controversial. The...
Saved in:
Main Authors: | Junji Saruwatari (Author), Takateru Ishitsu (Author), Kazuko Nakagawa (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2010-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Updated ILAE Review of Antiepileptic Drug Efficacy
by: J Gordon Millichap
Published: (2013) -
The influence of genetic polymorphisms in drug metabolism enzymes and transporters on the pharmacokinetics of different fluvastatin formulations
by: Qian Xiang, et al.
Published: (2020) -
Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters
by: Teresa Iannaccone, et al.
Published: (2021) -
Genetic polymorphism of carcinogen metabolic enzymes in oral submucous fibrosis
by: Sunu Ramachandran, et al.
Published: (2022) -
Antiepileptic Drug Monitoring
by: J Gordon Millichap
Published: (1995)